USNA EBITDA Margin
Usana Health Sciences Inc · EBITDA Margin
USNA EBITDA Margin
Latest reported4.57%period ending
USNA TTM EBITDA Margin (78.08% → 4.57%)
TTM ebitda margin
High-resolution chart · PNG
USNA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 4.5721% | |
| 8.6583% | |
| 8.8701% | |
| 9.1958% | |
| 10.7574% | |
| 10.7287% | |
| 11.5694% | |
| 13.2308% | |
| 13.2054% | |
| 13.5045% | |
| 13.3668% | |
| 12.8862% | |
| 12.9262% | |
| 12.838% | |
| 13.0405% | |
| 13.4364% | |
| 14.5166% | |
| 15.8062% | |
| 16.2577% | |
| 17.444% | |
| 17.538% | |
| 17.4534% | |
| 17.6579% | |
| 17.6154% | |
| 17.2885% | |
| 16.5467% | |
| 16.0665% | |
| 15.761% | |
| 16.0057% | |
| 16.9563% | |
| 17.2543% | |
| 16.8015% | |
| 16.0753% | |
| 15.0059% | |
| 14.4517% | |
| 14.0009% | |
| 14.4499% | |
| 14.8325% | |
| 14.7686% | |
| 15.3208% | |
| 15.82% | |
| 16.2863% | |
| 16.2551% | |
| 16.0032% | |
| 15.72% | |
| 15.3925% | |
| 15.8022% | |
| 16.2014% | |
| 16.5926% | |
| 17.5861% | |
| 18.1219% | |
| 18.4667% | |
| 17.6319% | |
| 16.341% | |
| 15.4882% | |
| 14.7406% | |
| 14.763% | |
| 14.7433% | |
| 14.7715% | |
| 14.7388% | |
| 14.9824% | |
| 14.6994% | |
| 14.8507% | |
| 14.7548% | |
| 13.972% | |
| 13.7452% | |
| 13.4243% | |
| 11.7262% | |
| 11.5631% | |
| 11.7957% | |
| 11.6081% | |
| 13.905% | |
| 15.0014% | |
| 15.6306% | |
| 17.3446% | |
| 17.7541% | |
| 18.2693% | |
| 18.5918% | |
| 17.9318% | |
| 18.0626% | |
| 17.9373% | |
| 17.8604% | |
| 18.2808% | |
| 17.8985% | |
| 17.8828% | |
| 17.5787% | |
| 16.9545% | |
| 16.9208% | |
| 16.5477% | |
| 16.1961% | |
| 16.0775% | |
| 15.0375% | |
| 13.6276% | |
| 12.004% | |
| 10.3262% | |
| 8.2603% | |
| 6.5667% | |
| 6.0015% | |
| 5.4795% | |
| 5.0234% |